Actuate Therapeutics Inc

Healthcare

NASDAQ:ACTU · NASDAQ Global Market

Market Cap $50.01M Beta 0.53 P/E (TTM) -2.3

$2.09 +2.96%

+$0.06 today

52W Low $1.58High $9.22

Vol 0.03M · Avg 0.16M

EPS (TTM) -$0.92Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-70.35%

Period High

$8.72

Period Low

$1.72

Latest

$2.09

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Nkarta, Inc.

NASDAQ:NKTX

$195.68M

Alector, Inc.

NASDAQ:ALEC

$174.86M

Molecular Partners AG

NASDAQ:MOLN

$148.22M

Spero Therapeutics, Inc.

NASDAQ:SPRO

$129.13M

PepGen Inc.

NASDAQ:PEPG

$120.70M

Vor Biopharma Inc.

NASDAQ:VOR

$103.52M

Elicio Therapeutics, Inc.

NASDAQ:ELTX

$71.95M

Seres Therapeutics, Inc.

NASDAQ:MCRB

$62.56M

VistaGen Therapeutics, Inc.

VTGN

$22.68M

Applied Therapeutics, Inc.

APLT

$14.86M

What is the latest ACTU filing?

The latest filing shown is 4 dated May 22, 2026.

How many recent filings does ACTU have?

Intrinsic Alpha currently shows 20 recent filings for ACTU.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.